Cited by

• DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness.

  Shao CP, Wang BY, Ye SH, Zhang WL, Xu H, Zhuang NB, Wu XY, Xu HG. Shao CP, et al. J Zhejiang Univ Sci B. 2012 Nov;13(11):913-8. doi: 10.1631/jzus.B1100348. J Zhejiang Univ Sci B. 2012. PMID: 23125084 Free PMC article.
• Planned Transfusion of D-Positive Blood Components in an Asia Type DEL Patient: Proposed Modification of the Korean National Guidelines for Blood Transfusion.

  Choi S, Chun S, Seo JY, Yang JH, Cho D. Choi S, et al. Ann Lab Med. 2019 Jan;39(1):102-104. doi: 10.3343/alm.2019.39.1.102. Ann Lab Med. 2019. PMID: 30215239 Free PMC article. No abstract available.
• An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.

  Wang QP, Dong GT, Wang XD, Gu J, Li Z, Sun AY, Shao CP, Pan ZL, Huang LH, Xie WX, Sun GM, Chen JJ, Pei H, Yang XJ, Shan PN. Wang QP, et al. Blood Transfus. 2014 Apr;12(2):238-43. doi: 10.2450/2013.0184-12. Epub 2013 Feb 6. Blood Transfus. 2014. PMID: 23399369 Free PMC article. Clinical Trial.
• Serologically D-negative blood donors in Thailand: molecular variants and diagnostic strategy.

  Nuchnoi P, Thongbut J, Bénech C, Kupatawintu P, Chaiwanichsiri D, Férec C, Fichou Y. Nuchnoi P, et al. Blood Transfus. 2023 May;21(3):209-217. doi: 10.2450/2022.0160-22. Epub 2022 Nov 4. Blood Transfus. 2023. PMID: 36346882 Free PMC article.
• A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite Normal RHD Exons.

  McGowan EC, Wu PC, Hellberg Å, Lopez GH, Hyland CA, Olsson ML. McGowan EC, et al. Transfus Med Hemother. 2024 May 10;51(4):252-264. doi: 10.1159/000538469. eCollection 2024 Aug. Transfus Med Hemother. 2024. PMID: 39021419 Free PMC article.